Collectively, Class I HDACs are capable of modulating the Akt, MAPK and mTOR signalling pathways, as well as the expression of genes associated with hypertrophy, thereby contributing to the initiation and progression of cardiac hypertrophy. This evidence concerns the gene AKT1 and cardiac hypertrophy.